Department of Clinical Biochemistry, University Hospital of Salamanca, Salamanca, Spain.
Statistical Department, University of Salamanca, Salamanca, Spain; Institute for Biomedical Research, IBSAL, Salamanca, Spain.
J Allergy Clin Immunol Pract. 2018 May-Jun;6(3):955-961.e1. doi: 10.1016/j.jaip.2017.10.006. Epub 2017 Nov 10.
Asthma is a heterogeneous chronic disease with different clinical expressions and responses to treatment. In recent years, several unbiased approaches based on clinical, physiological, and molecular features have described several phenotypes of asthma. Some phenotypes are allergic, but little is known about whether these phenotypes can be further subdivided.
We aimed to phenotype patients with allergic asthma using an unbiased approach based on multivariate classification techniques (unsupervised hierarchical cluster analysis).
From a total of 54 variables of 225 patients with well-characterized allergic asthma diagnosed following American Thoracic Society (ATS) recommendation, positive skin prick test to aeroallergens, and concordant symptoms, we finally selected 19 variables by multiple correspondence analyses. Then a cluster analysis was performed.
Three groups were identified. Cluster 1 was constituted by patients with intermittent or mild persistent asthma, without family antecedents of atopy, asthma, or rhinitis. This group showed the lowest total IgE levels. Cluster 2 was constituted by patients with mild asthma with a family history of atopy, asthma, or rhinitis. Total IgE levels were intermediate. Cluster 3 included patients with moderate or severe persistent asthma that needed treatment with corticosteroids and long-acting β-agonists. This group showed the highest total IgE levels.
We identified 3 phenotypes of allergic asthma in our population. Furthermore, we described 2 phenotypes of mild atopic asthma mainly differentiated by a family history of allergy.
哮喘是一种异质性的慢性疾病,具有不同的临床表型和治疗反应。近年来,基于临床、生理和分子特征的几种无偏方法已经描述了几种哮喘表型。一些表型是过敏的,但关于这些表型是否可以进一步细分知之甚少。
我们旨在使用基于多变量分类技术(无监督层次聚类分析)的无偏方法对过敏性哮喘患者进行表型分析。
从总共 225 名经过充分诊断的过敏性哮喘患者的 54 个变量(根据美国胸科学会 (ATS) 建议进行的皮试阳性、对空气过敏原的一致症状)中,我们通过多次对应分析最终选择了 19 个变量。然后进行聚类分析。
鉴定出 3 个组。组 1 由间歇性或轻度持续性哮喘、无特应性、哮喘或鼻炎家族史的患者组成。该组的总 IgE 水平最低。组 2 由具有轻度哮喘和特应性、哮喘或鼻炎家族史的患者组成。总 IgE 水平处于中间水平。组 3 包括需要皮质激素和长效β-激动剂治疗的中重度持续性哮喘患者。该组的总 IgE 水平最高。
我们在人群中确定了 3 种过敏性哮喘表型。此外,我们描述了 2 种轻度特应性哮喘表型,主要通过过敏家族史进行区分。